Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Start your free trial now

Instant access. No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: venlafaxine hydrochloride

« Back to Dashboard
Venlafaxine hydrochloride is the generic ingredient in three branded drugs marketed by Wyeth Pharms Inc, Anchen Pharms, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Mylan, Orchid Hlthcare, Teva, Torrent Pharms Llc, Valeant Pharms North, Wockhardt, Zydus Pharms Usa Inc, Osmotica Pharm, Sun Pharma Global, Alembic Pharms Ltd, Amneal Pharms, Aurobindo Pharma, Heritage Pharms Inc, Pliva Hrvatska Doo, Sandoz, Sun Pharm Inds Inc, Vintage, and Zydus Pharms Usa, and is included in twenty-six NDAs. There are five patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

This ingredient has eigthy-five patent family members in forty-four countries.

There are sixty-four drug master file entries for venlafaxine hydrochloride. Nineteen suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: venlafaxine hydrochloride

Tradenames:3
Patents:5
Applicants:22
NDAs:26
Drug Master File Entries: see list64
Suppliers: see list19
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details

Pharmacology for Ingredient: venlafaxine hydrochloride

Tentative approvals for VENLAFAXINE HYDROCHLORIDE

Applicant Application No. Form Dosage
<disabled><disabled>CAPSULE, EXTENDED RELEASE; ORAL75MG
<disabled><disabled>CAPSULE, EXTENDED RELEASE; ORAL150MG
<disabled><disabled>CAPSULE, EXTENDED RELEASE; ORAL37.5MG

Clinical Trials for: venlafaxine hydrochloride

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions
Status: Completed Condition: Healthy

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study
Status: Completed Condition: Healthy

Co-Administration of LDX (SPD489) and Venlafaxine XR (EFFEXOR XR) in Healthy Volunteers
Status: Completed Condition: Healthy

A Relative Bioavailability Study of 50 mg Venlafaxine Hydrochloride Tablets Under Fed Conditions
Status: Completed Condition: Healthy

Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels
Status: Active, not recruiting Condition: Bariatric Surgery; Gastric Bypass; Roux-en-Y Gastric Bypass

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions
Status: Completed Condition: Healthy

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc
EFFEXOR
venlafaxine hydrochloride
TABLET;ORAL020151-001Dec 28, 1993DISCNNo<disabled><disabled>
Pliva Hrvatska Doo
VENLAFAXINE HYDROCHLORIDE
venlafaxine hydrochloride
TABLET;ORAL078517-005Jun 13, 2008DISCNNo<disabled><disabled>
Heritage Pharms Inc
VENLAFAXINE HYDROCHLORIDE
venlafaxine hydrochloride
TABLET;ORAL078554-004Jan 9, 2009RXNo<disabled><disabled>
Pliva Hrvatska Doo
VENLAFAXINE HYDROCHLORIDE
venlafaxine hydrochloride
TABLET;ORAL078517-003Jun 13, 2008DISCNNo<disabled><disabled>
Sun Pharm Inds Inc
VENLAFAXINE HYDROCHLORIDE
venlafaxine hydrochloride
TABLET;ORAL078627-002Jun 13, 2008RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: venlafaxine hydrochloride

Country Document Number Publication Date
Japan4771565Sep 14, 2011
Estonia200000212Apr 16, 2001
Israel151450Aug 31, 2005
Uruguay25692Mar 31, 2000
Hungary9700589Mar 28, 2001
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc